Market Place
Sourcing Support
Dr. Reddy lab`s Generics Prednisone Receives Tentative Approval in US
08 Aug 2024 //
FDA
Vincerx Announces Compelling Efficacy of Enitociclib with Venetoclax
07 Jan 2024 //
GLOBENEWSWIRE
FDA approves J&J`s PARP combo drug Akeega for prostate cancer
12 Aug 2023 //
FDA
Health Canada approves Lynparza with abiraterone for patients with BRCA mCRPC
14 Jul 2023 //
BIOSPACE
Ibrutinib Plus Chemoimmunotherapy Fails to Improve PFS in Pretreated FL, MZL
20 Jun 2023 //
ONCLIVE
US FDA panel backs restricted use of AstraZeneca`s prostate cancer drug
02 May 2023 //
BUSINESS-STANDARD
Update on FDA Advisory Committee Vote on LYNPARZA® (olaparib)
28 Apr 2023 //
BUSINESSWIRE
MHRA approves prostate cancer combination therapy
21 Mar 2023 //
EUROPEAN PHARMACEUTICAL REVIEW
Lynparza`s final OS results come up short in PROpel study
17 Feb 2023 //
PRESS RELEASE
LYNPARZA With Abiraterone and Prednisone Approved in the EU for mCRPC
21 Dec 2022 //
PRESS RELEASE
LYNPARZA® in Combo With Abiraterone & Prednisone or Prednisolone Approved in EU
21 Dec 2022 //
BUSINESSWIRE
Enforcement Report - Week of August 17, 2022
17 Aug 2022 //
FDA
Lynparza combo accepted by FDA for priority review
17 Aug 2022 //
THEPHARMALETTER
Genentech lymphoma treatment gets FDA approval
16 Aug 2022 //
LABIOTECH
Lumicera Health Services Now Offering The First Landmark Drug From CivicaScript™
11 Aug 2022 //
BUSINESSWIRE
CivicaScript Announces Launch of its First Product
03 Aug 2022 //
BUSINESSWIRE
Improved outcome for prostate cancer patients in Phase III PROpel trial
22 Jun 2022 //
EUROPEANPHARMACEUTICALREVIEW
EC approves Roche’s Polivy combination in previously untreated diffuse LBCL
26 May 2022 //
EXPRESS PHARMA
Janssen Submits MAA for Niraparib & Abiraterone Acetate Dual Action Tablet
28 Apr 2022 //
BUSINESSWIRE
Aurobindo Pharma`s Generic Prednisone Receives Approval in the U.S.
28 Mar 2022 //
FDA
Zejula gives J&J mixed success in prostate cancer
14 Feb 2022 //
FIERCEPHARMA
Progression-Free Survival Boost Noted With Polatuzumab Vedotin Plus R-CHP
17 Dec 2021 //
CANCERNETWORK
Aurobindo Pharma`s Generic Prednisone Receives Approval In US
19 Nov 2021 //
FDA
Epizyme Announces Data from TAZVERIK Clinical Programs to be Presented ESMO 2021
14 Sep 2021 //
BUSINESSWIRE
Reduced Fatigue Reported With Abiraterone+Prednisone Treatment
19 Jul 2021 //
FIRSTWORDPHARMA
Novitium Pharma`s Generic Prednisone Receives Approval In US
06 Jul 2021 //
FDA
Strides Pharma`s Generic Prednisone Receives Approval In US
17 Feb 2021 //
FDA
Strides Pharma`s Generic Prednisone Receives Approval In US
24 Nov 2020 //
FDA
Strides Pharma Science gets USFDA nod for generic Prednisone tablets
23 Nov 2020 //
BUSINESSWIRE
Strides Pharma`s Generic PREDNISONE Receives Approval In The US
13 Sep 2020 //
FDA
Strides Pharma gets US FDA nod for generic anti-inflammatory drug
03 Sep 2020 //
BUSINESS STANDARD
Amneal Pharmaceuticals Generic Prednisone Receives Approval in US
24 Jun 2020 //
FDA
European Commission Approves ADCETRIS® (brentuximab vedotin)
14 May 2020 //
BUSINESSWIRE
EMA committee recommends approval of Takeda’s Adcetris in combo
01 Apr 2020 //
PHARMABIZ
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin)
31 Mar 2020 //
PRESS RELEASE
NIH funded study shows methotrexate is more effective than mycophenolate mofetil
13 Sep 2019 //
PHARMABIZ
Seattle Genetics investors breathe a sigh of relief as Adcetris posts 30% growth
17 Jul 2019 //
FIERCE PHARMA
Imprimis NJOF, LLC Receives FDA Warning Letter
09 Jul 2019 //
FDA
J&J`s Darzalex pads blockbuster sales with another myeloma nod in new patients
29 Jun 2019 //
FIERCE PHARMA
Geneyork Pharms` Generic Prednisone Receives Approval in US
28 Dec 2018 //
FDA
Health Canada Issues Recall of Apotex`s Prednisone Tablets
20 Dec 2018 //
HEALTH CANADA
Geneyork Pharms` Generic Prednisone Receives Approval in US
07 Dec 2018 //
FDA
Geneyork Pharms` Generic Prednisone Receives Approval in US
04 Dec 2018 //
FDA
Clozel hands over a rival to PTC’s controversial steroid deflazacort
20 Nov 2018 //
ENDPTS
Seattle Genetics Announces results of Broad ADCETRIS® (Brentuximab Vedotin)
01 Nov 2018 //
BUSINESSWIRE
Celltrion & Teva Announce FDA ODAC Recommends CT-P10 Approval
11 Oct 2018 //
BUSINESSWIRE
Janssen bags new EU approval for Darzalex
04 Sep 2018 //
PHARMA TIMES
Janssen Announces EC Approval of Darzalex (daratumumab) for MM
31 Aug 2018 //
BUSINESSWIRE
AbbVie, J&J’s Imbruvica fails to target in B-Cell lymphoma trial
12 Jul 2018 //
PHARMA TIMES
AbbVie Stock Drops After Disappointing Clinical Trial Update
12 Jul 2018 //
BIOSPACE
Henan Lihua Pharmaceutical Receives FDA warning Letter
26 Jun 2018 //
FDA
Safety scuppers combo trials with J&J/Genmab’s Darzalex
31 May 2018 //
PM LIVE
J&J preps for esketamine filing in resistant depression
08 May 2018 //
FIERCE BIOTECH
EMA to hold public hearing on quinolone and fluoroquinolone antibiotic safety
16 Mar 2018 //
PHARMACEUTICAL
J&J’s Darzalex shows promise in newly-diagnosed multiple myeloma
13 Dec 2017 //
PHARMA TIMES
J&J`s Darzalex wins big in first-line myeloma
12 Dec 2017 //
FIERCE PHARMA
As Zytiga’s importance grows, so does that of generics
16 Aug 2017 //
EP VANTAGE
Actavis Labs Generics Prednisone Receives Approval In US
27 Apr 2017 //
FDA
Xtandi, cornerstone of Pfizer`s $14B Medivation buy, falls short
16 Dec 2016 //
FIERCE PHARMA
